A potential microRNA signature for tumorigenic conazoles in mouse liver

Molecular Carcinogenesis

Volumn 49, Issue 4, 2010, Pages 320-323

  Ross, Jeffrey A ^a   Blackman, Carl F ^a   Thai, Sheau Fung ^a   Li, Zhiguang ^b   Kohan, Michael ^a   Jones, Carlton P ^a   Chen, Tao ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Conazole; Expression; Fungicides; MicroRNA; Tumorigenicity

Indexed keywords

FUNGICIDE; MESSENGER RNA; MICRORNA; MYCLOBUTANIL; PROPICONAZOLE; PYRROLE DERIVATIVE; TRIADIMEFON;

3' UNTRANSLATED REGION; ADOLESCENT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENT; GENE EXPRESSION; LIVER CARCINOGENESIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ISOLATION;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DOWN-REGULATION; FUNGICIDES, INDUSTRIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED STRAINS; MICRORNAS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NITRILES; POLYMERASE CHAIN REACTION; TRIAZOLES;

ANIMALIA; MUS;

EID: 77951655547     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20620     Document Type: Article

References (14)

1. USEPA. Triadimefon; pesticide tolerances for emergency exemptions. Fed Reg 1996;61:63721-63726.
2. USEPA. Propiconazole; time-limited pesticide tolerances. Fed Reg 2004;62:47005-47013.
3. USEPA. Myclobutanil; pesticide tolerances. Fed Reg 2000;65: 29963-29973.
4. Allen JW, Wolf DC, George MH, et al. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Toxicol Pathol 2006;34:853-862.
5. Ward WO, Delker DA, Hester SD, et al. Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Toxicol Pathol 2006;34:863-878. (Pubitemid 46011140)
6. Ross JA, Moore T, Leavitt SA. In vivo mutagenicity of conazole fungicides correlates with tumorigenicity. Mutagenesis 2009;24:149-152.
7. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
8. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-436.
9. Bartels CL, Tsongalis GJ. MicroRNAs: Novel biomarkers for human cancer. Clin Chem 2009;55:623-631.
10. Jeffrey SS. Cancer biomarker profiling with microRNAs. Nat Biotechnol 2008;26:400-401.
11. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121. (Pubitemid 32397092)
12. Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361:1437-1447.
13. Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009;69:1135-1142.
14. Nagel R, le Sage C, Diosdado B, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008;68:5795-5802.